Veracyte Inc (NASDAQ:VCYT)

9.63
Delayed Data
As of Apr 24
 +0.40 / +4.33%
Today’s Change
6.01
Today|||52-Week Range
18.00
-0.31%
Year-to-Date
No recent news for Veracyte Inc.

Today’s Trading

Previous close9.23
Today’s open9.29
Day’s range9.10 - 9.65
Volume116,815
Average volume (3 months)63,192
Market cap$208.2M
Dividend yield--
Data as of 3:59pm ET, 04/24/2015

Growth & Valuation

Earnings growth (last year)+77.89%
Earnings growth (this year)+4.69%
Earnings growth (next 5 years)--
Revenue growth (last year)+74.51%
P/E ratioNM
Price/Sales5.47
Price/Book5.02

Competitors

 Today’s
change
Today’s
% change
TROVTrovagene Inc-0.13-1.46%
CALACalithera Bioscience...-0.35-2.54%
TRILTrillium Therapeutic...+2.05+9.25%
QTNTQuotient Ltd-0.35-2.10%
Data as of 3:59pm ET, 04/24/2015

Financials

Next reporting dateMay 7, 2015
EPS forecast (this quarter)-$0.37
Annual revenue (last year)$38.2M
Annual profit (last year)-$29.4M
Net profit margin-76.91%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Bonnie H. Anderson
Chief Operating Officer
Christopher M. Hall
Corporate headquarters
South San Francisco, California

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers